EUVIMEDEUVIMED entdecken
Crossref

Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database

L A Wehrli, M L Reppucci, J Ketzer, A Dominguez-Muñoz, E H Cooper, A Peña, A Bischoff, L De La Torre

Pediatric Surgery International · 2023

DOI: 10.1007/s00383-023-05511-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Surgery International, 2023. Verfasst von L A Wehrli und 7 weiteren Autor:innen. Beteiligte Einrichtung: International Center for Colorectal and Urogenital Care, Children's Hospital Colorado, Aurora, CO, USA. Hauptthemen laut MEDLINE: Multiple Endocrine Neoplasia Type 2a, Hirschsprung Disease, Thyroid Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: Multiple endocrine neoplasia Type 2A (MEN2A) can occur with Hirschsprung disease (HD) due to mutation in the RET proto-oncogene, with the majority developing medullary thyroid carcinoma (MTC). Given the comorbidity, many parents have contacted us to share concerns and unfortunate experiences about the prevalence rates of MEN2A/MTC in patients with HD. The aim is to determine the prevalence rate of patients with HD and MEN2A or medullary thyroid carcinoma, respectively. METHODS: This is a cross-sectional study of the COSMOS database from January 01, 2017, to March 08, 2023. The database was searched for patients diagnosed with MEN2A, MTC, and HD. IRB exemption was provided (COMIRB #23-0526). RESULTS: The database contained 183,993,122 patients from 198 contributing organizations. The prevalence of HD and MEN2A was 0.00002%, and for HD and MTC was 0.000009%. One in 66 patients (1.5%) with MEN2A also had HD. One in 319 patients (0.3%) in the HD group had MEN2A. One in 839 patients (0.1%) within the HD population had MTC. CONCLUSION: The prevalence of MTC and HD or MEN2A and HD in the study population was low. Considering that almost all MEN2A patients have a positive family history, this data does not support the general genetic testing of HD patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple Endocrine Neoplasia Type 2aHirschsprung DiseaseThyroid NeoplasmsCross-Sectional StudiesProto-Oncogene Proteins c-retHumansIncidenceCarcinoma, Neuroendocrine

Stichwörter der Autor:innen

HirschsprungMEN-2AMEN-2BMedullary Thyroid Carcinoma

Substanzen

Proto-Oncogene Proteins c-ret

Autor:innen und Institutionen

  • International Center for Colorectal and Urogenital Care, Children's Hospital Colorado, Aurora, CO, USA.
  • Research in Outcomes for Children's Surgery, Center for Children's Surgery, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, USA.
  • International Center for Colorectal and Urogenital Care, Children's Hospital Colorado, Aurora, CO, USA. luis.delatorre@childrenscolorado.org.

Zitieren

APA

Wehrli, L. A., Reppucci, M. L., Ketzer, J., Dominguez-Muñoz, A., Cooper, E. H., Peña, A., Bischoff, A., & De La Torre, L. (2023). Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database. Pediatric Surgery International. https://doi.org/10.1007/s00383-023-05511-0

Vancouver

Wehrli LA, Reppucci ML, Ketzer J, Dominguez-Muñoz A, Cooper EH, Peña A, et al. Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database. Pediatric Surgery International. 2023. doi:10.1007/s00383-023-05511-0

BibTeX
@article{Wehrli2023,
  author = {Wehrli, L A and Reppucci, M L and Ketzer, J and Dominguez-Muñoz, A and Cooper, E H and Peña, A and Bischoff, A and De La Torre, L},
  title = {Incidence of medullary thyroid carcinoma and Hirschsprung disease based on the cosmos database},
  journal = {Pediatric Surgery International},
  year = {2023},
  doi = {10.1007/s00383-023-05511-0}
}
Kostenlos starten →